Cytek Biosciences CTKB Cash Flow Statement (2020-2026)

NASDAQ CTKB
$4.76 +0.06 (+1.17%)
At close: Aug 20, 2026 · 12:10 PM UTC
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
1.42M-1.17M-2.16M-0.70M1.63M3.72M-6.84M-4.39M-6.46M5.50M-6.19M-10.43M0.96M9.60M-11.40M-5.58M-5.47M-44.03M-18.87M-12.16M
Depreciation and Depletion (Quarter)
0.19M0.35M0.30M0.40M0.40M0.50M0.50M0.60M0.90M0.80M0.80M0.90M0.90M0.90M0.90M1.00M1.00M1.00M1.00M1.10M
Share-based Compensation (Quarter)
2.46M3.01M3.84M3.93M4.36M-12.13M4.70M5.92M-10.62M22.05M5.64M-5.64M1.64M1.08M6.63M6.79M5.64M5.53M4.86M5.34M
Deferred Taxes (Quarter)
-2.89M-0.34M-2.06M-2.63M38.58M-0.18M
Gains from Investment Securities (Quarter)
-0.08M-1.58M-2.12M-1.56M-1.40M-1.20M-1.18M-1.25M-1.58M-1.49M-1.61M-1.35M-1.21M-1.25M-1.30M
Asset Writedowns and Impairment (Quarter)
0.07M0.15M0.07M0.21M0.17M0.29M0.01M0.78M0.67M0.91M-0.98M1.72M0.31M-0.26M0.41M-0.05M0.19M0.17M
Cash from Operations (Quarter)
1.16M5.45M-1.48M-9.44M-7.50M6.19M2.86M-2.85M-4.24M9.51M3.96M6.20M13.22M2.00M-0.12M0.11M-3.90M-0.77M-2.74M1.37M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.68M0.69M0.70M1.10M0.80M0.80M0.79M0.79M0.76M0.67M0.96M0.89M1.01M1.10M1.14M1.15M0.95M0.98M
Depreciation & Amortization (CF) (Quarter)
0.19M0.69M0.79M0.86M0.07M0.76M1.00M1.65M1.77M1.63M1.70M1.81M1.85M1.85M1.88M1.89M1.92M1.90M1.86M2.01M
Change in Working Capital
Change in Receivables (Quarter)
5.59M0.72M1.04M6.93M3.82M7.96M-6.05M6.80M6.85M-0.26M-4.24M-5.92M6.25M9.33M-6.45M-0.65M0.59M6.15M-9.64M-1.97M
Change in Inventory (Quarter)
0.96M2.23M5.92M8.43M5.18M-1.88M3.19M-3.03M1.89M-6.33M-4.77M-4.43M-3.56M-2.00M1.50M3.57M2.22M-2.05M1.63M2.86M
Change in Account Payables (Quarter)
0.64M-0.74M2.78M0.90M-0.91M-0.91M0.30M-2.00M1.71M-1.79M0.61M-0.52M2.23M0.26M0.41M0.76M0.59M-1.31M0.39M1.74M
Change in Accured Expenses (Quarter)
1.59M8.88M0.56M2.23M0.04M4.64M1.76M-1.49M0.34M0.12M-4.60M-4.79M5.63M2.94M-2.12M2.79M-1.41M4.71M-3.89M4.12M
Change in Taxes (Quarter)
0.18M
Other Working Capital Changes (Quarter)
4.08M3.38M4.35M4.31M6.37M4.33M0.14M3.03M-0.83M7.18M2.92M-2.34M1.49M0.74M0.15M1.43M0.28M1.74M-3.85M2.25M
Investing Activities
Capital Expenditures (Quarter)
2.73M1.30M0.23M1.88M1.11M6.53M0.14M-0.11M3.12M-3.11M0.57M1.05M-1.52M0.08M0.23M-0.19M3.04M-2.95M2.17M2.22M
Sales of Property, Plant and Equipment (Quarter)
0.08M0.02M0.19M0.03M0.02M0.00M0.20M0.01M0.00M
Acquisitions (Quarter)
44.90M0.00M0.47M
Change in Acquisitions & Divestments (Quarter)
10.00M68.00M54.00M72.00M40.00M38.00M45.00M70.43M66.47M79.20M76.11M70.71M70.57M
Cash from Investing Activities (Quarter)
-1.31M-18.30M-0.78M-2.92M-1.15M-51.06M-168.87M2.79M43.12M29.07M-5.75M2.02M-15.81M-63.43M9.45M-16.41M18.92M-1.84M-27.08M7.02M
Financing Activities
Other financing activities (Quarter)
215.37M0.36M0.45M0.23M0.17M0.20M0.76M0.16M0.34M0.51M0.22M0.15M0.14M0.04M0.06M0.14M0.09M0.02M0.83M
Cash from Financing Activities (Quarter)
217.08M0.02M0.36M1.14M0.15M3.85M0.22M-8.27M-33.75M1.61M-1.71M-12.08M-3.64M-11.54M-2.60M1.94M-1.23M3.98M-0.81M
Additional items
Exchange Rate Effect (Quarter)
-0.01M0.68M-0.22M-1.40M0.13M-1.00M-1.09M-1.01M1.47M-0.82M1.70M2.26M-0.94M1.52M-1.23M-0.92M0.85M1.41M0.65M0.61M
Change in Cash (Quarter)
-204.38M409.15M-2.11M-12.61M-8.37M-42.02M-167.11M-0.85M32.09M4.00M1.51M8.78M-15.62M-63.56M-3.45M-19.83M17.81M-2.43M-25.19M8.18M
Free Cash Flow (Quarter)
-1.57M4.15M-1.71M-11.32M-8.61M-0.34M2.72M-2.74M-7.36M12.62M3.39M5.15M14.74M1.92M-0.36M0.30M-6.94M2.18M-4.90M-0.85M
Net Cash Flow (Quarter)
216.93M-12.83M-1.90M-11.21M-8.50M-41.02M-166.02M0.16M30.61M4.82M-0.18M6.51M-14.67M-65.08M-2.22M-18.91M16.96M-3.84M-25.83M7.58M